crown

Subscribe Now

FOLLOW US

Sign in

serum institute of india

PAGE 2

SII’s multivalent meningococcal meningitis vaccine gets WHO prequalification

Updated on Jul 12, 2023 12:31 IST

The vaccine protects against meningococcal serogroups A, C, W, Y, and X. (HT file image)

RIL tops list of Indian companies, Serum Institute first among unlisted: Report

Reliance Industries Limited's Mukesh Ambani (Left) and Serum Institute of India's Adar Poonawalla

Published on Jun 20, 2023 12:28 IST

HC restrains 2 influencers from posting defamatory content against SII, Covishield

HT Image

Updated on Jun 5, 2023 19:33 IST

Bombay HC restrains activists from posting defamatory content on SII, Covishield

Serum Institute of India chief executive officer Adar Poonawalla. (File)

Updated on Jun 5, 2023 09:58 IST

ED attaches Zavaray Soli Poonawalla’s assets worth ₹41.64 crore in Worli

Mumbai, February 22, 2015 : Behroze and Zavaray Poonawalla at the 26th Poonawalla Breeders Multi-Million (PBMM), race in Mumbai. (HT Photo) (Hindustan Times)

Updated on May 8, 2023 19:20 IST

‘Fema violation’ case: ED seizes ₹41.64cr assets of Pune bizman

A statement issued by the ED said it has “seized three immovable properties located at Ceejay house, Worli, Mumbai, worth <span class='webrupee'>₹</span>41.64 crore under the provisions of FEMA in its probe against Zavareh Soli Poonawalla and his family members”. (HT)

Updated on May 8, 2023 19:04 IST

UK Investment Min inaugurates British Trade office in Pune

PM Modi had visited city-based SERUM institute back in 2021. (HT PHOTO)

Updated on Apr 28, 2023 17:59 IST

Serum Institute of India to produce 5mn Covishield doses in two months

Adar Poonawalla, chief executive officer of Serum Institute of India (SII). (HT PHOTO)

Updated on Apr 22, 2023 17:31 IST

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

SII chief executive officer Adar Poonawalla.

Published on Apr 22, 2023 09:38 IST

India's Serum Institute resumes Covishield production as Covid cases surge

Adar Poonawalla, CEO of Serum Institute of India

Published on Apr 12, 2023 12:08 IST

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

The letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) on March 27, they said.

Published on Apr 3, 2023 14:40 IST

Oxford, Serum initiative: Anti-malaria vaccine’s Phase 3 trials conclude

According to WHO, malaria is a life-threatening disease caused by Plasmodium parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes.

Published on Dec 6, 2022 03:03 IST

Serum Institute Whatsapp duping case: Seven held from various states

Serum Institute of India CEO Adar Poonawalla.

Published on Nov 25, 2022 14:02 IST

SII's Adar Poonawalla expects Omicron-specific vaccine in 6 months: Report

Adar Poonawalla, CEO of Serum Institute of India (SII), the world's biggest vaccine maker.

Published on Aug 15, 2022 18:06 IST

Monkeypox: As India sees rise in cases, what Adar Poonawalla said about vaccine

Adar Poonawalla, chief executive officer of Serum Institute of India Ltd. (Bloomberg)

Published on Aug 2, 2022 12:11 IST

Serum institute seeks government nod to export Covovax to the US

SII chief executive officer Adar Poonawalla. (REUTERS)

Published on Jun 30, 2022 21:46 IST

Govt panel recommends market authorisation for Serum's cervical cancer vaccine

The SII is also learnt to have made a presentation before the working group of HPV constituted separately by the NTAGI to review the data and usefulness of this vaccine last Wednesday.

Published on Jun 15, 2022 17:07 IST

Covovax gets govt nod for 12-18 age group at private centres

Currently, while Covishield is available for all adults, Bharat Biotech’s Covaxin is available for those aged 15 and above. Corbevax is being used for children in the 12-15 age group (HT FILE)

Published on May 3, 2022 18:07 IST

'Covovax now available for children in India', says Adar Poonawalla, hails Modi

Updated on May 10, 2022 14:27 IST

Made in India Covid vaccines better than Pfizer, Moderna: SII's Adar Poonawalla

On being asked about the export of the Covishield Covid-19 vaccine, Adar Poonawalla

Published on Apr 13, 2022 10:52 IST

Covishield booster shots to be priced at ₹600 plus taxes: Adar Poonawalla

Covishield has been manufactured by Pune-based Serum Institute of India, which is the world's largest vaccine maker.

Updated on Apr 8, 2022 13:24 IST

Can’t disclose data on trials: Vaccine makers to Supreme Court

A student receives a dose of a Covid vaccine in Noida. (HT photo/Sunil Ghosh)

Updated on Mar 22, 2022 23:34 IST

Give full authorisation to Covishield: Serum Institute of India

Ranchi, Dec 28 (ANI): A beneficiary receives a dose of the COVID-19 vaccine during a door-to-door vaccination programme, at Deoghar, in Ranchi on Tuesday. (ANI Photo) (Somnath Sen)

Updated on Dec 31, 2021 17:37 IST

Serum Institute of India applies for full approval of Covishield Covid vaccine

Serum Institute, which is also the world's biggest vaccine maker, was granted approval for emergency use of Covishield in India at the beginning of the year.

Published on Dec 31, 2021 08:18 IST

Covovax gets WHO’s nod for emergency use

Covovax is part of the WHO-led Covax facility. SII began stockpiling doses in the summer and a Union health ministry assessment in June said the government expects 200 million doses of the vaccine to be available by December.

Published on Dec 17, 2021 20:44 IST

Vaccine maker SII pledges $66 million to Oxford University

The research building would be named after Serum's billionaire owners, the Poonawalla family. The pledge builds on the collaboration between Oxford University, AstraZeneca and SII

Published on Dec 15, 2021 24:20 IST

Omicron: Will India allow booster dose? Here's what central expert panel said

More than 60 countries across the world have already authorised booster doses of the Covid-19 vaccine, said the central government in a written reply to Parliament this week.

Published on Dec 11, 2021 02:23 IST

Serum Institute seeks DCGI nod for Covishield booster shot amid Omicron scare

Prakash Kumar Singh, director of government and regulatory affairs at Pune-based SII, mentioned in his letter to DCGI that the UK’s Medicines and Healthcare products regulatory agency has already approved the booster doses of AstraZeneca ChAdOx1 nCoV-19 vaccine.

Published on Dec 1, 2021 17:45 IST

Serum Institute of India resumes exports of Covishield vaccine to COVAX facility

SII said its supply of doses through COVAX was expected to increase substantially into the first quarter of 2022.

Published on Nov 26, 2021 12:54 IST

Delay in SII’s first shipment to Nepal under Covax

Serum Institute may ship 20-30 million doses of Covishield by the end of the year, the company has said in the past. (AFP)

Updated on Nov 23, 2021 21:17 IST

1
2

Home / India News / Serum institute of india

© 2026 HindustanTimes